Notte, Gregory,Lapina, Olga,Chiu, Anna,Carra, Ernest,Andres, Mark,Chan, Brenda,Lathrop, Stephen,Smolenskaya, Valeriya,Yu, Lok
申请号：
NZ73244115
公开号：
NZ732441A
申请日:
2015.12.22
申请国别(地区):
NZ
年份:
2018
代理人:
摘要：
Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state: Also provided are processes of manufacture and methods of using the crystalline forms including treating a disease mediated, at least in part, by ASK1, such as an inflammatory condition.
